Wegovy® is a clinically proven, once-weekly injectable medication containing semaglutide, specifically developed for chronic weight management in adults with overweight or obesity, or those with weight-related medical conditions.

How It Works

Wegovy® mimics a natural hormone (GLP-1) that targets areas of the brain responsible for appetite regulation. It helps:

• Reduce hunger and cravings
• Increase feelings of fullness
• Support portion control
• Improve long-term weight management

Structured Dose Escalation

Treatment starts at a lower dose and gradually increases to allow the body to adjust and minimize side effects:

• 0.25 mg – Starter dose (initiation phase)
• 0.5 mg – Early titration phase
• 1 mg – Continued dose adjustment
• 1.7 mg – Pre-maintenance phase
• 2.4 mg – Full maintenance dose

This step-by-step approach must be followed under medical supervision.

Doctor-Supervised Weight Loss

Wegovy® is available by prescription only and requires:

• Medical evaluation
• Doctor consultation (teleconsultation or clinic visit)
• Ongoing monitoring during treatment

Supervised treatment ensures proper dosing, safety monitoring, and personalized weight-loss guidance.

Who May Benefit

Wegovy® may be suitable for adults who:

• Have a BMI ≥30, or
• Have a BMI ≥27 with weight-related conditions (e.g., hypertension, type 2 diabetes, high cholesterol)

A doctor will assess eligibility before starting treatment.

Delivery & Payment Information

• Delivery available nationwide across Thailand or clinic self pick-up available
• Payment method: CASH or QR Code only (for now)
• Bangkok delivery: Within 1 day
• Outside Bangkok: 2–3 business days